Description
+ Include: 51 videos + 1 pdf, size: 2.85 GB
+ Target Audience: oncologist
+ Sample video: contact me for sample video
+ Information:
The 18TH Annual New Orleans Summer Cancer Meeting (NOSCM) is the largest continuing medical education (CE) event in the US Southeast region. It is a 3-day national CE, nursing education (CE), pharmacist and physician assistant meeting designed for medical oncologists, hematologists, surgical oncologists, radiation oncologists, oncology nurses, nurse practitioners, pharmacists, physician assistants, residents and fellows in Hematology/Oncology as well as other healthcare professionals involved in the management of cancer patients. The 18th Annual NOSCM will have a long list of experts in the field of malignant diseases; guest faculty will discuss important topics in the management of cancer patients not only novel therapies such as immunotherapy, targeted agents and cytotoxic agents but also management of side effects, survivorship, palliative care, liquid biopsy, and biosimilars in oncology.
The meeting will have deep discussions on immunotherapy for different tumor types. Immunotherapy has improved overall survival of many tumor types; how to improve these outcomes and how to deal with immunotherapy resistance will be discussed during this educational activity. Based on evaluations from the previous 16 consecutive years, this meeting will offer healthcare professionals with the necessary tools and clinical knowledge to provide the best quality of care to their patients.
The 18th edition of this national CE program will focus on integrating major advances in basic sciences and how to apply them into the routine clinical practice, and hence, deliver precision medicine to each individual patient. Using platforms such as DNA and RNA next generation sequencing, now we can detect DNA genomic abnormalities as well as fusion proteins with RNA analysis. The length of the NOSCM allows plenty of time for the audience to engage in discussion of different topics in medical oncology and hematology. It is very important that audience share their thoughts with national and international thought leaders in the fields of liquid and solid cancers. We are honored to have guest faculty represented by expert clinicians and researchers from premier cancer centers in the United States.
+ Topics:
Agenda.pdf
Breast Cancer Session Drug Development and New Targeted Agents for Breast Cancer What Does the Future Hold.mp4
Breast Cancer Session Immunotherapy for Breast Cancer Current and Future Directions.mp4
Breast Cancer Session Optimal Treatment for Early Stage HER Positve Breast Cancer.mp4
Breast Cancer Session Sequencing Endocrine Therapy and Targeted Agents for the Treatment of Metastatic HR+ HER2- Breast Cancer.mp4
Gastrointestinal Cancers Bringing Personalized Medicine to Colorectal Cancers.mp4
Gastrointestinal Cancers ctDNA in Adjuvant and Metastatic Therapy for GI Cancers Prime Time.mp4
Geriatric Oncology Prostate Cancer Geriatric Oncology Pitfalls to Deliver Good Care in the Elderly Cancer Patient.mp4
Geriatric Oncology Prostate Cancer Novel RT Approaches in Prostate Cancer.mp4
Geriatric Oncology Prostate Cancer Prostate Cancer Targeted, Hormonal & Novel Pathways in mCRPC.mp4
Hematology Session I Follicular lymphoma Defining Best 1L and 2L Treatment in the Era of Personalized Medicine.mp4
Hematology Session I Novel Therapeutic Advances for DLBCL & Hodgkin’s Disease.mp4
Hematology Session I T-Cell NHL Novel Approaches & Challenges.mp4
Hematology Session I The Art-of-Medicine in Treating Chronic Lymphocytic Leukemia.mp4
Hematology Session II De Novo Acute Myeloid Leukemia.mp4
Hematology Session II Myelodysplastic Syndrome Challenges, Current Standard Therapy and Future Directions.mp4
Hematology Session II Navigating Payor Barriers to Access of Oncology Pharmaceuticals Real-World Case Approach.mp4
Hematology Session II Redefining Treatment Algorithms in B-cell Lymphomas A Focus on CAR-T Cell Therapy.mp4
Hematology Session III How to Choose the Best 1L in a Newly Diagnosed Multiple Myeloma Patient.mp4
Hematology Session III How to Navigate Through Relapsed-Refractory Myeloma Patient.mp4
Hematology Session III Thrombophilia & Thrombosis in Cancer Patients Novel Advances.mp4
Hematology Session III Waldenstrom’s Macroglobulinemia.mp4
Immunotherapy Session Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies.mp4
Immunotherapy Session Immunotherapy in Kidney & Bladder Cancer.mp4
Immunotherapy Session Melanoma What is after immunotherapy More immunomodulation.mp4
Immunotherapy Session Novel Advances in Head and Neck Cancer What is after IO.mp4
Immunotherapy Session Toxicities in Immunotherapy.mp4
IO Neuro Toxicity Radiotherapy in Oncology How to Combine RT and Immunotherapy Without Compromising Anti-tumor Effect.mp4
IO Neuro Toxicity Radiotherapy in Oncology Management of Neurological Toxicities from Immunotherapy Diagnosis, Assessement and Therapy.mp4
IO Neuro Toxicity Radiotherapy in Oncology Novel Advances in RT for Oligometastatic Disease.mp4
Sarcoma Thymoma-Thymic Ca Disparity in Cancer Cancer Disparity from Different Angles How to Tackle It.mp4
Sarcoma Thymoma-Thymic Ca Disparity in Cancer GIST and Soft Tissue Sarcomas Focus on Personalized Medicine.mp4
Sarcoma Thymoma-Thymic Ca Disparity in Cancer Lack of Access to Novel Cancer Therapies How to Deal and Approach this Problem.mp4
SPECIAL SESSION Presentation by Patient Advocate Walking Alongside Patients in Cancer.mp4
Supportive Care Telemedicine Artificial Intelligence Medicine Artificial Intelligence in Oncology Care.mp4
Supportive Care Telemedicine Artificial Intelligence Medicine Management of Osteonecrosis of Jaw and Other Complications from Bisphosphonate and or RANK Ligand Inhibitors.mp4
Supportive Care Telemedicine Artificial Intelligence Medicine Medical Marijuana Who, When & How.mp4
Supportive Care Telemedicine Artificial Intelligence Medicine Survivorship in the Modern Era of Cancer Care Goals, Measures, and Outcomes.mp4
Supportive Care Telemedicine Artificial Intelligence Medicine Telemedicine in Oncology.mp4
Thoracic Oncology Session I ALK Choosing 1L & Mechanism of Resistance.mp4
Thoracic Oncology Session I ctDNA in Lung Cancer Current State and Future Perspectives.mp4
Thoracic Oncology Session I Identifying and Targeting Mechanisms of Resistance to 3rd Generation EGFR Inhibitors.mp4
Thoracic Oncology Session I Novel Advances in Mesothelioma.mp4
Thoracic Oncology Session I Pre-Operative and Metastatic Setting Biomarkers for Immunotherapy in Lung Cancer.mp4
Thoracic Oncology Session II ADC in NSCLC CEACAM5 and Teliso-V.mp4
Thoracic Oncology Session II ADC in NSCLC TROP2 and HER3 in NSCLC.mp4
Thoracic Oncology Session II EGFRex20ins, METex14 and RET in NSCLC.mp4
Thoracic Oncology Session II Immunotherapy in Advanced Metastatic NSCLC and What After IO Failures.mp4
Thoracic Oncology Session II K-RAS and ERBB2 Mutation in NSCLC.mp4
Thoracic Oncology Session II Neoadjuvant and Adjuvant Immunotherapy in Early Stage Lung Cancer.mp4
Thoracic Oncology Session II Novel Treatment for Unresectable Stage III NSCLC.mp4
Thoracic Oncology Session II Small Cell Lung Cancer 1L and Beyond.mp4
Reviews
There are no reviews yet.